United States Diagnostics & Research news

00:39 30 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

GRAIL to Announce Second Quarter 2026 Financial Results

GRAIL, Inc. (Nasdaq: GRAL) announced it will release its second-quarter 2026 financial results after market close on Wednesday, August 5, 2026. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

00:11 30 Jul 2026

finance.yahoo.com Analyst action Main company 🇺🇸 United States

IQVIA (IQV) Stock Sees Modest Fair Value Lift After Mixed Analyst Target Changes

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. IQVIA Holdings just saw its internal fair value price target move from US$226.95 to …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:06 30 Jul 2026

Sahm Earnings Main company 🇺🇸 United States

Agilent Technologies (A) Could Be 14% Undervalued Following FDA Cancer Test Approval

Agilent Technologies (A) stock is garnering attention after its PD-L1 IHC 28-8 pharmDx assay received FDA approval as a companion diagnostic for several gastrointestinal cancers. The company's share price saw positive returns recently, and a Simply Wall St analysis suggests the stock could be …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

00:00 30 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies (ADPT) Reports Q2 Earnings: What Key Metrics Have to Say

Adaptive Biotechnologies (ADPT) reported $71.55 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 21.5%. EPS of -$0.10 for the same period compares to -$0.17 a year ago. The reported revenue represents a surprise of +7.98% over the Zacks …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

23:42 29 Jul 2026

scanx.trade Earnings Main company 🇺🇸 United States

ICON plc Q2 Results: Revenue rises 1.2% YoY, adjusted EPS falls

ICON plc reported a 1.2% year-on-year revenue increase in Q2 2026, reaching $2,063.5 million, but saw its adjusted EPS decline to $2.56 due to restructuring and integration costs. Despite this, the company reaffirmed its full-year 2026 adjusted EPS guidance of $10.00-$11.00 and revenue guidance …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

23:14 29 Jul 2026

Sharemaestro News Company research Main company 🇺🇸 United States

Labcorp’s 4.8M-share week puts the 52-week high back in reach as diagnostics breadth splits

LH rose 4.7% to $296.8, just 0.6% below its 52-week high, with volume at 1.5 times its 13-week average. The setup is constructive, but Sharemaestro reads it as balanced rather than decisive.

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

23:09 29 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Bragar Eagel & Squire, P.C. Reminds GRAIL, Inc. Investors They Have Until August 4th to Contact the Firm Seeking Lead Plaintiff Rol

Bragar Eagel & Squire, P.C. has announced a class action lawsuit against GRAIL, Inc. (NASDAQ:GRAL) for allegedly making false and misleading statements regarding its NHS Galleri trial. Investors who purchased GRAIL common stock between May 13, 2025, and February 19, 2026, and suffered losses …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

22:46 29 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Quest Diagnostics SVP Mark Delaney sells $376k in shares

Mark E. Delaney, SVP and CCO at Quest Diagnostics Inc. (NASDAQ: DGX), sold 1,600 shares for $376,288 on July 28, 2026, conducted under a Rule 10b5-1 sales plan. This transaction occurred as the stock neared its 52-week high, after a significant 12% gain. The …

DGX main company

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

22:40 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

FBLG|Fibrobiologics Inc|Price:0.655|Chg%:+0.004

Fibrobiologics Inc (FBLG) closed at $0.719, up 9.85% on July 29, 2026, with a market capitalization of $2.39 million. Analysts currently rate FBLG as a "Buy" with a target price of $13.50, suggesting a significant upside. The company is a clinical-stage biotechnology firm developing …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

22:39 29 Jul 2026

Quiver Quantitative Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies (ADPT) Releases Q2 2026 Earnings: Revenue Growth but Still Unprofitable

Adaptive Biotechnologies (ADPT) reported Q2 2026 revenues of $71.6 million, marking a 21.5% year-over-year increase and surpassing analyst estimates. Despite this revenue growth and improved gross profit, the company remained unprofitable, posting a net loss of $39.8 million. Insider trading data shows significant sales …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

22:11 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

CUE|Cue Biopharma Inc|Price:28.600|Chg%:+0.590

Cue Biopharma Inc. (CUE) shows healthy fundamentals and high growth potential, despite a recent stock price decline. The company's valuation is considered fairly valued within the Biotechnology & Medical Research industry, with high institutional ownership and a "Buy" rating from analysts. Its Immuno-STAT platform …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

22:03 29 Jul 2026

Yahoo! Finance Canada Earnings Provider-linked mention 🇺🇸 United States

Powell Industries, Inc. (POWL) Stock Forecasts

Argus has lowered its target price for Powell Industries Inc. (POWL) to $236.00. Powell Industries is a U.S.-based company specializing in custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The current stock price for POWL is $186.39.

DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

21:55 29 Jul 2026

MarketWatch Earnings Main company 🇺🇸 United States

Waters Corp. stock underperforms Wednesday when compared to competitors

Waters Corp. (WAT) stock fell 1.15% on Wednesday, closing at $379.48 and underperforming the broader market, which also experienced a decline. The S&P 500 Index dropped 1.52%, and the Dow Jones Industrial Average fell 2.19%. Waters Corp.'s stock is now 8.37% below its 52-week …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

21:52 29 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Castle Biosciences CEO Maetzold sells $237,682 in company stock

Castle Biosciences CEO Derek J. Maetzold sold $237,682 worth of company stock through direct sales and various trusts on July 27, 2026, under a Rule 10b5-1 trading plan. Despite the sales, Maetzold also acquired 6,214 shares by exercising vested stock options. The company is …

CSTL main company

Sharemaestro market context Price above Trend Line 52 weeks +42.1%

21:52 29 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $150,130.24 in Stock

Castle Biosciences (NASDAQ:CSTL) insider Derek Maetzold sold 6,214 shares of the company's stock, totaling $150,130.24, under a pre-arranged Rule 10b5-1 plan. This transaction reduced his ownership by 22.44%. The company's stock was trading up 2.4% at $24.46, and analysts maintain a "Moderate Buy" consensus …

CSTL main company

Sharemaestro market context Price above Trend Line 52 weeks +42.1%

21:49 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Medpace Holdings (MEDP) EVP sells 7,500 shares of stock at $600

Medpace Holdings, Inc. EVP, Operations, Susan E. Burwig, sold 7,500 shares of common stock at $600 per share on July 28, 2026, totaling $4.5 million. The sale was executed via a limit order during an open window period, leaving her with 62,984 shares directly …

MEDP main company

Sharemaestro market context Trend signal active 52 weeks +24.8% · Next-week setup positive 59.0%

21:49 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Medpace Holdings (NASDAQ: MEDP) CEO sells 7,238 shares at ~$600

Medpace Holdings CEO August J. Troendle sold 7,238 common shares in open-market transactions on July 27-28, 2026, at weighted average prices around $600 per share. These sales were executed under a limit order during an open window period and were not made under a …

MEDP main company

Sharemaestro market context Trend signal active 52 weeks +24.8% · Next-week setup positive 59.0%

21:42 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

ICON plc (NASDAQ: ICLR) Q2 2026 results show bookings strength and lower EPS

ICON plc reported Q2 2026 revenue of $2,063.5 million, marking a 1.2% year-on-year increase, but saw GAAP diluted EPS fall significantly to $0.94 from $2.56 a year earlier, and adjusted diluted EPS to $2.56 from $3.52. Despite the earnings compression and a $32.9 million …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

21:39 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

CNTB|Connect Biopharma Holdings Ltd|Price:2.207|Chg%:+0.157

This article provides a comprehensive stock analysis of Connect Biopharma Holdings Ltd (CNTB) by TradingKey. It highlights the company's strong fundamentals and high growth potential, despite a recent weak stock market performance. The article details CNTB's valuation as fairly valued within its industry, significant …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

21:11 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

GRAIL webcast on Aug. 5 results open to all interested parties

GRAIL (Nasdaq: GRAL) will announce its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

21:10 29 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

ILLUMINA, INC. (ILMN) names Chief Commercial Officer as insider with no holdings

Illumina, Inc. (ILMN) identified Michael C. Sullivan, its Chief Commercial Officer, as a reporting person for insider ownership purposes. This Form 3 filing indicates that Sullivan currently holds no reportable equity, derivative positions, or insider transactions with the company. The disclosure establishes his insider …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

21:10 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Two Guardant Health investor chats are set for Aug. 12 and Sept. 15

Guardant Health, a precision oncology company, announced its participation in two upcoming investor conferences: the Canaccord Genuity 46th Annual Growth Conference on August 12th in Boston, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15th in New York. The company will …

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

21:08 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

IQVIA HOLDINGS INC. SEC Filing (Jul 29, 2026)

This article details an SEC Form 144 filing by IQVIA Holdings Inc. (IQV) on July 29, 2026. The filing indicates a proposed sale of 5,000 shares of common stock with an aggregate market value of $1,245,775, acquired through performance shares on February 6, 2024, …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

21:05 29 Jul 2026

finance.yahoo.com Market update Main company 🇺🇸 United States

Guardant Health to Participate in Upcoming Investor Conferences

PALO ALTO, Calif., July 29, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Canaccord Genuity 46th Annual Growth Conference in Boston, MA Fireside chat on Wednesday, August 12th at …

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

21:05 29 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results

Adaptive Biotechnologies SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

20:55 29 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

Danaher Corp. stock underperforms Wednesday when compared to competitors

Danaher Corp. (DHR) stock fell by 1.29% to $196.49 on Wednesday, ending a two-day winning streak. This underperformance occurred during a generally poor trading session, with the S&P 500 Index (SPX) dropping 1.52% and the Dow Jones Industrial Average (DJIA) declining 2.19%.

DHR main company

Sharemaestro market context Price above Trend Line 52 weeks -3.7%

20:37 29 Jul 2026

Investing.com Earnings Provider-linked mention 🇺🇸 United States

Elanco Named Top Pick in Animal Health by Bank of America

Bank of America has named Elanco Animal Health Incorporated (NYSE:ELAN) its top pick in the Animal Health sector, reiterating a Buy rating due to the company's clear catalyst profile and potential for upside in earnings estimates. In contrast, BofA maintains a Neutral rating on …

IDXX mentioned

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

20:12 29 Jul 2026

GuruFocus Analyst action Main company 🇺🇸 United States

IQV Maintained by Stifel -- Price Target Raised to $276.00

Stifel has maintained a 'Buy' rating for IQVIA Holdings (IQV) and increased its price target from $220.00 to $276.00, reflecting optimism about the company's future performance. According to GuruFocus, IQV is currently slightly undervalued by 1.7% with a GF Value™ of $250.52 and boasts …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

20:03 29 Jul 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

BlackRock (PSNL holder) discloses 5.9% beneficial stake in Personalis common stock

BlackRock, Inc. has reported a 5.9% beneficial ownership stake in Personalis, Inc. (PSNL) common stock as of June 30, 2026. This ownership, totaling 6,169,729 shares, grants BlackRock sole voting power over 6,051,493 shares and sole dispositive power over all 6,169,729 shares, as detailed in …

PSNL main company

Sharemaestro market context Trend signal active 52 weeks +190.7%

19:39 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

AIMD|Ainos Inc|Price:1.360|Chg%:+0.040

This article provides a comprehensive stock analysis of Ainos Inc (AIMD) from TradingKey. It highlights the company's relatively stable fundamentals, significant growth potential, and fair valuation within the Biotechnology & Medical Research industry. The analysis also covers institutional ownership, recent weak stock market performance, …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

19:39 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies' MRD Business Grew 33%; clonoSEQ Volume Reached 36,111

Adaptive Biotechnologies (ADPT) reported strong Q2 2026 financial results, with overall revenue up 22% to $71.6 million, largely driven by its Minimal Residual Disease (MRD) business, which grew 33% year-over-year. The company also announced plans to separate its MRD and Immune Medicine businesses, completed …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

19:39 29 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies (Nasdaq: ADPT) boosts MRD 2026 guidance after Q2 revenue hits $71.6M

Adaptive Biotechnologies (ADPT) announced strong second-quarter 2026 results, with total revenue reaching $71.6 million, a 22% year-over-year increase, primarily driven by its Minimal Residual Disease (MRD) segment which grew 33%. The company raised its full-year 2026 MRD revenue guidance to $268–$278 million and completed …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

19:08 29 Jul 2026

globenewswire.com Regulatory and legal Main company 🇺🇸 United States

GRAL INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the August 4, 2026 Lead Plaintiff Deadline in the Grail, Inc. Securities Class Action

ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Grail, Inc. (“Grail”) (NASDAQ: GRAL). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding the probability of achieving the …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

18:39 29 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Veracyte, Inc. Revenue Breakdown – TRADEGATE:12V

Veracyte, Inc. generated €440.31 million in revenue last year, primarily from its Diagnostic Tests and Biopharmaceutical Services segment. The United States was the leading contributor to this revenue, accounting for €422.81 million. This shows an increase in both total revenue and U.S. contributions compared …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

18:38 29 Jul 2026

TradingKey Earnings Main company 🇺🇸 United States

WAT|Waters Corp|Price:371.191|Chg%:-8.289

This article provides a comprehensive stock analysis for Waters Corp (WAT), highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Healthcare Equipment & Supplies industry. It details the company's TradingKey Stock Score, including insights on institutional ownership, analyst ratings, and …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

18:35 29 Jul 2026

globenewswire.com Regulatory and legal Main company 🇺🇸 United States

TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Grail Class Action Lawsuit - GRAL

SAN DIEGO, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and February 19, 2026, both dates inclusive (the “Class Period”), …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%